How do we slow down progression, for Progressive MS Patients?
Published June 1, 2015 Ashley Ringstaff, of MS World, asks Dr. Jack Burks, how we can slow progression for those…
Highlights from the American Academy of Neurology’s 2015 Annual Meeting – includes PPMS updates
The American Academy of Neurology’s (AAN’s) 67th Annual Meeting took place in Washington, DC April 18th-25th. The AAN is an…
Stuart Schlossman
MS News in Australia: New SPMS Trial underway
The MIS416 trial is a clinical research trial1 now enrolling patients with Secondary Progressive Multiple Sclerosis (SPMS) in Australia. Full information about…
Stuart Schlossman
Progressive MS: Looking for answers NOW
Impressive reading for thousands seeking answers By Douglas Landsman Apr 28, 2015 People who live with progressive MS have many questions, but…
Stuart Schlossman
Firm Claims Biotin Drug Improves Function in Progressive MS
One-year study meets primary disability-based endpoint, company says To read, CLICK: http://www.medpagetoday.com/MeetingCoverage/AAN/51048 ~~~~~~~~~~~~~~~~~~~~ Keep CURRENT with MS Views and News – OPT-IN…
Stuart Schlossman
MedDay provides update on pioneering pivotal Phase III study design in Progressive Multiple Sclerosis
~ Phase III data to be disclosed at AAN Annual Meeting in Clinical Trials Plenary Session on April 24th 2015…
Stuart Schlossman
Seeking Answers for Progressive MS
An invitational meeting in Boston marks a step forward in a concerted international push to find effective therapies to target…
Stuart Schlossman
Experimental SPMS Drug From Innate Therapeutics Shows Success in Early Trials
FEBRUARY 13TH, 2015 MAUREEN NEWMAN Under development at Innate Immunotherapeutics is a special drug candidate to treatsecondary progressive multiple sclerosis (SPMS). Currently, no viable therapies…
Stuart Schlossman
PPMS news – 100th patient enrolled in multiple sclerosis study
Published 12:30 am Thursday, January 22, 2015 By Emily Ford For the Duke Translational Medicine Institute A Raleigh medical practice…
Stuart Schlossman
What are the most promising approaches to treating progressive MS?
Progressive multiple sclerosis represents a significant management challenge, so we asked three well-known researchers and clinicians to share their thoughts…
Stuart Schlossman
